Theralase Technologies Inc. V.TLT

Interesting !

[Oden6570]

ASCO GU 2021: Optimal Therapy for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer in the Non-cystectomy Candidate - Intravesical

[Rumpl3StiltSkin]

nice digging Thor! Seems TLT has to just get those % CR rates up a bit to be the domiant intravesical therapy.

[Oden6570]

Agreed that is my takeaway as well. I like our safe 1 maybe 2 treatment options much better. If not for dosing errors grrrrrrrr !

[ScienceFirst]

We're not in there: The Latest Research on Bladder Cancer - UroToday We're not in there: Clinical Trials in Urology - UroToday By chance, we now have US sites. __________________________________ Oden6570 - (2/18/2021 5:57:17 AM) Interesting ! ASCO GU 2021: Optimal Therapy for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer in the Non-cystectomy Candidate

[Eoganacht]

As usual, Dr. Kamat did not mention us in his Feb. 3 article. But we did get a mention by Dr. Black, our principle investigator at UBC, in his 2020 conference presentation posted on the site: EAU 2020: Immunotherapy and Beyond: New Options for Non-Muscle Invasive Bladder Cancer Yeah, we got left out of their NMIBC clinical trial list. I'll try and write them and see if they'll fix it. It

[enriquesuave]

A while back Dr Kamat said we needed more data.  At next  round of official PH2 data, i hope we make headlines and Dr Kamat mentions us.  It's no point talking efficacy data yet on such a small number of patients especially since initial group was undertreated IMO.  But at least after 6-10 optimized treated patients or more, then there will be enough to talk about.

[CancerSlayer]

Enrique wrote... "A while back Dr Kamat said we needed more data.  At next  round of official PH2 data, i hope we make headlines and Dr Kamat mentions us.  It's no point talking efficacy data yet on such a small number of patients especially since initial group was undertreated IMO.  But at least after 6-10 optimized treated patients or more, then there will be

[CancerSlayer]

  The above highlight should read...40% "12 month" CR...

[CancerSlayer]

Thanks Eoganacht....I noted the US trial sites need updating as well.  However, we are mentioned on the CURC website...under current trials, bladder cancer.  At least Dr. Black has our back.  He also mentioned the importance of always "having other options available". Immunotherapeutics will always have their limitations, & so we'll always need an open door to

[Eoganacht]

I contacted URO TODAY and, as I suspected, our trial had been mis-categorized. They took immediate action upon receiving my email, relocating our trial so it shows up in the NMIBC search results. If you now search for NMIBC clinical trials TLD-1433 will show up on the second page of results - 4th from the top. If a NMIBC patient is searching for a clinical trial to be a part of it's important

[enriquesuave]

Excellent job!  Thanks

[Jaro1977]

great Eoganancht!

[skys1]

Why did Eoganacht have to do this? Why didn't the company????

[skyhawk1]

GREAT QUESTION?! We need to ask them about this?